Defibrotide in the Human Endotoxemia Model --- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide

NCT02876601 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers
Endotoxemia

Interventions

DRUG: Defibrotide
DRUG: Placebo (0.9% sodium chloride)
DRUG: Lipopolysaccharide
DRUG: Placebo (0.9% sodium chloride bolus)

Sponsor

Bernd Jilma